Pages that link to "Q36616823"
The following pages link to Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer (Q36616823):
Displaying 20 items.
- Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion. (Q34286158) (← links)
- Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. (Q34516136) (← links)
- Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma. (Q34998460) (← links)
- PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples (Q35470322) (← links)
- BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study (Q36265444) (← links)
- High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation (Q36354166) (← links)
- Soluble heparin-binding EGF-like growth factor (HB-EGF) detected by newly developed immuno-PCR method is a clear-cut serological biomarker for ovarian cancer (Q36383078) (← links)
- Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells (Q36752057) (← links)
- Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor (Q37022647) (← links)
- A multivariate model of ErbB network composition predicts ovarian cancer cell response to canertinib (Q37205345) (← links)
- Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells. (Q37697198) (← links)
- Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy (Q37802152) (← links)
- Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells. (Q38803572) (← links)
- Cross-reacting material 197 reverses the resistance to paclitaxel in paclitaxel-resistant human ovarian cancer (Q38819410) (← links)
- Identification of diphtheria toxin R domain mutants with enhanced inhibitory activity against HB-EGF. (Q38937127) (← links)
- Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression (Q38952915) (← links)
- Endocytosis of Ubiquitylation-Deficient EGFR Mutants via Clathrin-Coated Pits is Mediated by Ubiquitylation (Q41832305) (← links)
- EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo (Q47156089) (← links)
- A targetable HB-EGF-CITED4 axis controls oncogenesis in lung cancer. (Q51042385) (← links)
- EGFR signaling patterns are regulated by its different ligands. (Q55070997) (← links)